OBJECTIVE: Neuroimaging and other biomarker assays suggest that the pathological processes of Alzheimer's disease (AD) begin years prior to clinical dementia onset. However, some 30 to 50% of older individuals who harbor AD pathology do not become symptomatic in their lifetime. It is hypothesized that such individuals exhibit cognitive resilience that protects against AD dementia. We hypothesized that in cases with AD pathology, structural changes in dendritic spines would distinguish individuals who had or did not have clinical dementia. METHODS: We compared dendritic spines within layer II and III pyramidal neuron dendrites in Brodmann area 46 dorsolateral prefrontal cortex using the Golgi-Cox technique in 12 age-matched pathology-free controls, 8 controls with AD pathology (CAD), and 21 AD cases. We used highly optimized methods to trace impregnated dendrites from bright-field microscopy images that enabled accurate 3-dimensional digital reconstruction of dendritic structure for morphologic analyses. RESULTS: Spine density was similar among control and CAD cases but was reduced significantly in AD. Thin and mushroom spines were reduced significantly in AD compared to CAD brains, whereas stubby spine density was decreased significantly in CAD and AD compared to controls. Increased spine extent distinguished CAD cases from controls and AD. Linear regression analysis of all cases indicated that spine density was not associated with neuritic plaque score but did display negative correlation with Braak staging. INTERPRETATION: These observations provide cellular evidence to support the hypothesis that dendritic spine plasticity is a mechanism of cognitive resilience that protects older individuals with AD pathology from developing dementia. Ann Neurol 2017;82:602-614.
OBJECTIVE: Neuroimaging and other biomarker assays suggest that the pathological processes of Alzheimer's disease (AD) begin years prior to clinical dementia onset. However, some 30 to 50% of older individuals who harbor AD pathology do not become symptomatic in their lifetime. It is hypothesized that such individuals exhibit cognitive resilience that protects against AD dementia. We hypothesized that in cases with AD pathology, structural changes in dendritic spines would distinguish individuals who had or did not have clinical dementia. METHODS: We compared dendritic spines within layer II and III pyramidal neuron dendrites in Brodmann area 46 dorsolateral prefrontal cortex using the Golgi-Cox technique in 12 age-matched pathology-free controls, 8 controls with AD pathology (CAD), and 21 AD cases. We used highly optimized methods to trace impregnated dendrites from bright-field microscopy images that enabled accurate 3-dimensional digital reconstruction of dendritic structure for morphologic analyses. RESULTS: Spine density was similar among control and CAD cases but was reduced significantly in AD. Thin and mushroom spines were reduced significantly in AD compared to CAD brains, whereas stubby spine density was decreased significantly in CAD and AD compared to controls. Increased spine extent distinguished CAD cases from controls and AD. Linear regression analysis of all cases indicated that spine density was not associated with neuritic plaque score but did display negative correlation with Braak staging. INTERPRETATION: These observations provide cellular evidence to support the hypothesis that dendritic spine plasticity is a mechanism of cognitive resilience that protects older individuals with AD pathology from developing dementia. Ann Neurol 2017;82:602-614.
Authors: B Jacobs; M Schall; M Prather; E Kapler; L Driscoll; S Baca; J Jacobs; K Ford; M Wainwright; M Treml Journal: Cereb Cortex Date: 2001-06 Impact factor: 5.357
Authors: Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer Journal: Neuron Date: 2014-08-21 Impact factor: 17.173
Authors: R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman Journal: Ann Neurol Date: 1991-10 Impact factor: 10.422
Authors: Erik B Bloss; William G Janssen; Daniel T Ohm; Frank J Yuk; Shannon Wadsworth; Karl M Saardi; Bruce S McEwen; John H Morrison Journal: J Neurosci Date: 2011-05-25 Impact factor: 6.167
Authors: Dani Dumitriu; Jiandong Hao; Yuko Hara; Jeffrey Kaufmann; William G M Janssen; Wendy Lou; Peter R Rapp; John H Morrison Journal: J Neurosci Date: 2010-06-02 Impact factor: 6.167
Authors: Elizabeth Head; Maria M Corrada; Kristin Kahle-Wrobleski; Ronald C Kim; Floyd Sarsoza; Matthew Goodus; Claudia H Kawas Journal: Neurobiol Aging Date: 2007-11-14 Impact factor: 4.673
Authors: Kelsey M Greathouse; Benjamin D Boros; Josue F Deslauriers; Benjamin W Henderson; Kendall A Curtis; Erik G Gentry; Jeremy H Herskowitz Journal: Brain Struct Funct Date: 2018-09-08 Impact factor: 3.270
Authors: Mario Merlini; Victoria A Rafalski; Pamela E Rios Coronado; T Michael Gill; Maya Ellisman; Gayathri Muthukumar; Keshav S Subramanian; Jae Kyu Ryu; Catriona A Syme; Dimitrios Davalos; William W Seeley; Lennart Mucke; Robert B Nelson; Katerina Akassoglou Journal: Neuron Date: 2019-02-05 Impact factor: 17.173
Authors: Kaitlin B Casaletto; Miguel Arce Rentería; Judy Pa; Sarah E Tom; Amal Harrati; Nicole M Armstrong; K Bharat Rajan; Dan Mungas; Samantha Walters; Joel Kramer; Laura B Zahodne Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Julie C Lauterborn; Conor D Cox; See Wing Chan; Peter W Vanderklish; Gary Lynch; Christine M Gall Journal: Brain Pathol Date: 2019-09-08 Impact factor: 6.508
Authors: Eider M Arenaza-Urquijo; Scott A Przybelski; Timothy L Lesnick; Jonathan Graff-Radford; Mary M Machulda; David S Knopman; Christopher G Schwarz; Val J Lowe; Michelle M Mielke; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri Journal: Brain Date: 2019-04-01 Impact factor: 13.501
Authors: William M Webb; Ashleigh B Irwin; Mark E Pepin; Benjamin W Henderson; Victoria Huang; Anderson A Butler; Jeremy H Herskowitz; Adam R Wende; Andrew E Cash; Farah D Lubin Journal: Biol Psychiatry Date: 2019-06-12 Impact factor: 13.382